tumor necrosis factor therapy

Known as: therapy, TNF, therapy, tumor necrosis factor, tnf therapy 
A biological therapy that involves the use of anti-tumor necrosis factor antagonists. It results in the inhibition of tumor necrosis factor and the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
010203019912017

Related topics

Related topics

2 relations

Broader (1)

Immunotherapy
cytokine therapy

Related mentions per year

Related mentions per year

1947-2018
19401960198020002020
tumor necrosis factor therapy
Immunotherapy
cytokine therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
Chronic inflammation has been implicated in the pathogenesis of many severe autoimmune disorders, as well as in diabetes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
OBJECTIVE To evaluate the validity, responsiveness, and predictive value of power Doppler ultrasonography (PDUS) monitoring of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
OBJECTIVE To ascertain the relationship between anti-tumor necrosis factor (anti-TNF) therapy, methotrexate (MTX), and the risk… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary…
OBJECTIVE To determine the efficacy and safety of treatment with rituximab plus methotrexate (MTX) in patients with active… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British…
OBJECTIVE To determine whether the rate of serious infection is higher in anti-tumor necrosis factor (anti-TNF)-treated… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
Administration of anti-tumor necrosis factor (anti-TNF) agents is beneficial in a variety of chronic inflammatory conditions… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
OBJECTIVE Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF) antagonists is highly effective, but their… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
OBJECTIVE Granulomatous inflammation is a typical feature of Takayasu arteritis (TA), and tumor necrosis factor (TNF) is… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.
BACKGROUND Previously, we showed that tumor necrosis factor (TNF) antagonism with etanercept, a soluble TNF receptor, was well… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
To define a role for the cytokine tumor necrosis factor (TNF) in immune-mediated demyelination, the effect of anti-TNF antibody… (More)
Is this relevant?